A quality of life study for people with bladder cancer (LABC study)

Cancer type:

Bladder cancer

Status:

Open

Phase:

Other

This is a study of the quality of life for people who have been newly diagnosed with bladder cancer and who are living with and beyond bladder cancer.

It is for people who have been diagnosed and treated for bladder cancer in the Yorkshire, North Derbyshire, South Tees and Humber regions.

More about this trial

There is information about the treatment of bladder cancer and how the treatment affects the quality of life Open a glossary item. Most of this information is about people with bladder cancer that is more likely to grow very fast and spread. 
 
There is less information about the quality of life of people who have just been diagnosed. And who have lived for many years after their diagnosis. 
 
In this study researchers hope to find out more about how a diagnosis of bladder cancer and living with bladder cancer affects quality of life.
 
There are 2 groups in this study, those who:
  • are newly diagnosed with bladder cancer
  • have had a diagnosis of bladder cancer in the past 10 years
The aims of this study are to find out what the quality of life is like for people diagnosed with bladder cancer:
  • in the year after diagnosis
  • in the years following their diagnosis

Who can enter

The following bullet points list the entry conditions for this study. Talk to your doctor or the trial team if you are unsure about any of these. They will be able to advise you. 
 
The study team are looking at 2 groups of people. 
 
The first are people who are newly diagnosed with bladder cancer. This is called the longitudinal group.
 
The second are people who were diagnosed bladder cancer in the past 10 years. This is called the cross sectional group. 
 
Newly diagnosed (Longitudinal group)
 
Who can take part
 
You may be able to join the longitudinal group if all of the following apply. You:
  • have been diagnosed with bladder cancer for the first time in the past 3 months
  • can understand English
  • can complete the survey either by yourself or with help
  • are at least 18 years old
Who can’t take part
 
You cannot join the longitudinal group if any of these apply. You:
  • have had a previous diagnosis of bladder cancer
  • have any other medical or mental health condition that could affect you taking part
  • are in prison 
Diagnosed in the past 10 years (Cross sectional group)
 
Who can take part
 
You may be able to join the cross sectional group if all of the following apply. You:
  • were diagnosed with bladder cancer in the past 10 years
  • were diagnosed at one of the NHS hospitals in the Yorkshire, North Derbyshire, South Tees and Humber regions
  • can complete the survey either by yourself or with help
  • are at least 18 years old
Who can’t take part
 
You cannot join the cross sectional group if you are:
  • taking part in the longitudinal study group
  • are in prison

Trial design

 
There are 2 groups in this study. People newly diagnosed (longitudinal group) and people who were diagnosed up to 10 years ago (cross sectional group). 
 
Newly diagnosed (Longitudinal group)
The study team need about 1,900 people to join this group.  
 
You fill in a questionnaire after your diagnosis at:
  • about 3 months
  • 6 months
  • 9 months
  • 12 months
The questions asked are about your:
  • general health
  • symptoms
  • treatment
  • side effects of treatment, if you have any
  • work life
  • home life
  • relationships
  • social life
The questionnaire takes about 30 minutes to do. You don’t have to answer all the questions at once. You can take your time. 
 
The team would like you to answer all the questions even if you don’t have any problems. 
 
You can do the questionnaire:
  • on paper, a freepost envelope is provided for its return
  • online, a team member will tell you how to do this
  • on the phone, by ringing the study helpline
Diagnosed in the last 10 years (Cross sectional group)
The team need about 4,000 people to join this group. 
 
You are sent a letter of invitation from the study team. This will contain
information about the study and a questionnaire. On the front page is a statement of consent. To consent you must tick the box and date it. 
 
The questionnaire takes about 30 minutes to do. You don’t have to answer all the questions at once. You can take your time. 
 
The team would like you to answer all the questions even if you don’t have any problems. 
 
You can do the questionnaire:
  • on paper, a freepost envelope is provided for its return
  • online, a team member will tell you how to do this
  • on the phone, by ringing the study helpline
You fill in the questionnaire once only in this group.
 

Hospital visits

For people in the longitudinal group there are no extra hospital visits if you agree to take part. 

For people who were diagnosed in the last 10 years group there are no hospital visits if you agree to take part. 

Side effects

There are no side effects if you take part in this study.

Location

Airedale
Barnsley
Bradford
Chesterfield
Doncaster
Goole
Harrogate
Huddersfield
Hull
Leeds
Middlesbrough
Northallerton
Rotherham
Sheffield
Wakefield
York

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Professor James Catto
Professor Adam Glaser

Supported by

University of Sheffield
University of Leeds
Yorkshire Cancer Research

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

15563

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Over 60,000 cancer patients enrolled on clinical trials in the UK last year.

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think